Anti-Suicide Drugs Market By Drug Class and End User - Global Industry Analysis & Forecast to 2025

Published On : February 2019 Pages : 155 Category: Pharma & Healthcare Report Code : HC022436

Anti-Suicide Drugs Market By Drug Class (Anti-anxiety drugs, NMDA Antagonists, Anti-depressants, Anti-psychotic drugs, Antibiotic analogues) End User (Clinics, Retail pharmacies, Hospitals, Online pharmacies) - Global Industry Analysis & Forecast to 2025

Industry Outlook and Trend Analysis

The Anti-Suicide Drugs Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Suicide is wherein an individual intentionally to kill oneself. This inclination is related with different emotional and mental issues, for example, personality disorder, depression, alcoholism, substance abuse, financial distress, impulsiveness due to stress, and troubled relationships, among others. Also, changing way of life and expanding societal issues help in the high self-destructive propensities, principally among young adults. Self-destructive tendencies are known to be higher among ladies than in men. Increasing demand for psychotherapy for the treatment of this condition is expanding which thus is probably going to add to the development of the anti-suicide drugs market.

Drivers and Restraints

As indicated by the WHO, near 800,000 individuals submit suicide annually. It is viewed as the second driving reason for death among young adults in the age gathering of 15 years to 29 years. As indicated by the American Foundation for Suicide Prevention, suicide is one of the main reasons of death in the U.S., with more than 43,000 deaths every year. As per the American Foundation for Suicide Prevention, the suicide rate was over 12.93 per 1,000 individuals in 2014 in the U.S. Changing conclusion of the populace identified with psychological health, increased focus on research and development leading to the launch of a range of drugs, growing awareness, and a solid pipeline of medications add to the development of the anti-suicide drugs market.

Regional Insights

North America represented a high share of the market in 2016, intently pursued by Europe. North America and Europe are foreseen to pick up footing attributable to expanded social insurance spending and dispatch of a scope of hostile to anti-suicidal drugs.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Allergan plc
  • H. Lundbeck A/S
  • Johnson & Johnson
  • Pfizer, Inc.
  • AstraZeneca plc
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Merck & Co., Inc

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Anti-Suicide Drugs Market, By Drug Class, Estimates and Forecast, 2014-2025 ($Million)

·         Anti-anxiety drugs

·         NMDA Antagonists

·         Anti-depressants

·         Anti-psychotic drugs

·         Antibiotic analogues

·         Anti-Suicide Drugs Market, By End User, Estimates and Forecast, 2014-2025 ($Million)

·         Clinics

·         Retail pharmacies

·         Hospitals

·         Online pharmacies

·         Anti-Suicide Drugs Market, By Region, Estimates and Forecast, 2014-2025 ($Million)

·         North America

§  North America Anti-Suicide Drugs Market, By Country

o    U.S. Anti-Suicide Drugs Market

o    Canada Anti-Suicide Drugs Market

o    Mexico Anti-Suicide Drugs Market

·         Europe

§  Europe Anti-Suicide Drugs Market, By Country

o    Germany Anti-Suicide Drugs Market

o    UK Anti-Suicide Drugs Market

o    France Anti-Suicide Drugs Market

o    Russia Anti-Suicide Drugs Market

o    Italy Anti-Suicide Drugs Market

o    Rest of Europe Anti-Suicide Drugs Market

·         Asia-Pacific

§  Asia-Pacific Anti-Suicide Drugs Market, By Country

o    China Anti-Suicide Drugs Market

o    Japan Anti-Suicide Drugs Market

o    South Korea Anti-Suicide Drugs Market

o    India Anti-Suicide Drugs Market

o    Southeast Asia Anti-Suicide Drugs Market

o    Rest of Asia-Pacific Anti-Suicide Drugs Market

·         South America

§  South America Anti-Suicide Drugs Market

o    Brazil Anti-Suicide Drugs Market

o    Argentina Anti-Suicide Drugs Market

o    Columbia Anti-Suicide Drugs Market

o    Rest of South America Anti-Suicide Drugs Market

·         Middle East and Africa

§  Middle East and Africa Anti-Suicide Drugs Market

o    Saudi Arabia Anti-Suicide Drugs Market

o    UAE Anti-Suicide Drugs Market

o    Egypt Anti-Suicide Drugs Market

o    Nigeria Anti-Suicide Drugs Market

o    South Africa Anti-Suicide Drugs Market

o    Rest of MEA Anti-Suicide Drugs Market

 

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Anti-Suicide Drugs Market, By Drug Class

5.1.     Introduction

5.2.     Global Anti-Suicide Drugs Revenue and Market Share by Drug Class (2014-2018)

5.2.1.  Global Anti-Suicide Drugs Revenue and Revenue Share by Drug Class (2014-2018)

5.3.     Anti-anxiety drugs

5.3.1.  Global Anti-anxiety drugs Revenue and Growth Rate (2014-2018)

5.4.     NMDA Antagonists

5.4.1.  Global NMDA Antagonists Revenue and Growth Rate (2014-2018)

5.5.     Anti-depressants

5.5.1.  Global Anti-depressants Revenue and Growth Rate (2014-2018)

5.6.     Anti-psychotic drugs

5.6.1.  Global Anti-psychotic drugs Revenue and Growth Rate (2014-2018)

5.7.     Antibiotic analogues

5.7.1.  Global Antibiotic analogues Revenue and Growth Rate (2014-2018)

6.       Anti-Suicide Drugs Market, By End User

6.1.     Introduction

6.2.     Global Anti-Suicide Drugs Revenue and Market Share by End User (2014-2018)

6.2.1.  Global Anti-Suicide Drugs Revenue and Revenue Share by End User (2014-2018)

6.3.     Clinics

6.3.1.  Global Clinics Revenue and Growth Rate (2014-2018)

6.4.     Retail pharmacies

6.4.1.  Global Retail pharmacies Revenue and Growth Rate (2014-2018)

6.5.     Hospitals

6.5.1.  Global Hospitals Revenue and Growth Rate (2014-2018)

6.6.     Online pharmacies

6.6.1.  Global Online pharmacies Revenue and Growth Rate (2014-2018)

7.       Anti-Suicide Drugs Market, By Region

7.1.     Introduction

7.2.     Global Anti-Suicide Drugs Revenue and Market Share by Regions

7.2.1.  Global Anti-Suicide Drugs Revenue by Regions (2014-2018)

7.3.     North America Anti-Suicide Drugs by Countries

7.3.1.  North America Anti-Suicide Drugs Revenue and Growth Rate (2014-2018)

7.3.2.  North America Anti-Suicide Drugs Revenue (Million USD) by Countries (2014-2018)

7.3.3.  United States

7.3.3.1.  United States Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.4.  Canada

7.3.4.1.  Canada Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.5.  Mexico

7.3.5.1.  Mexico Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.     Europe Anti-Suicide Drugs by Countries

7.4.1.  Europe Anti-Suicide Drugs Revenue and Growth Rate (2014-2018)

7.4.2.  Europe Anti-Suicide Drugs Revenue (Million USD) by Countries (2014-2018)

7.4.3.  Germany

7.4.3.1.  Germany Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.4.  France

7.4.4.1.  France Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.5.  UK

7.4.5.1.  UK Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.6.  Russia

7.4.6.1.  Russia Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.7.  Italy

7.4.7.1.  Italy Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.     Asia-Pacific Anti-Suicide Drugs by Countries

7.5.1.  Asia-Pacific Anti-Suicide Drugs Revenue and Growth Rate (2014-2018)

7.5.2.  Asia-Pacific Anti-Suicide Drugs Revenue (Million USD) by Countries (2014-2018)

7.5.3.  China

7.5.3.1.  China Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.4.  Japan

7.5.4.1.  Japan Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.5.  Korea

7.5.5.1.  Korea Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.6.  India

7.5.6.1.  India Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.     South America Anti-Suicide Drugs by Countries

7.6.1.  South America Anti-Suicide Drugs Revenue and Growth Rate (2014-2018)

7.6.2.  South America Anti-Suicide Drugs Revenue (Million USD) by Countries (2014-2018)

7.6.3.  Brazil

7.6.3.1.  Brazil Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.4.  Argentina

7.6.4.1.  Argentina Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.5.  Columbia

7.6.5.1.  Columbia Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.     Middle East and Africa Anti-Suicide Drugs by Countries

7.7.1.  Middle East and Africa Anti-Suicide Drugs Revenue and Growth Rate (2014-2018)

7.7.2.  Middle East and Africa Anti-Suicide Drugs Revenue (Million USD) by Countries (2014-2018)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.5.  Egypt

7.7.5.1.  Egypt Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.7.  South Africa

7.7.7.1.  South Africa Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.8.  Turkey

7.7.8.1.  Turkey Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)

8.       Company Profiles

8.1.     Allergan plc

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     H. Lundbeck

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Johnson & Johnson

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Pfizer, Inc.

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     AstraZeneca plc

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Eli Lilly and Company

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     GlaxoSmithKline plc

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Merck & Co., Inc

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

9.       Global Anti-Suicide Drugs Market Competition, by Manufacturer

9.1.     Global Anti-Suicide Drugs Revenue and Market Share by Manufacturer (2016-2017)

9.2.     Global Anti-Suicide Drugs Price By Region (2016-2017)

9.3.     Top 5 Anti-Suicide Drugs Manufacturer Market Share

9.4.     Market Competition Trend

10.    Anti-Suicide Drugs Market Forecast (2018-2025)

10.1. Global Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2018-2025)

10.2. Anti-Suicide Drugs Market Forecast by Regions (2018-2025)

10.2.1.      North America Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.1.1. United States Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.1.2. Canada Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.1.3. Mexico Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.2.      Europe Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.2.1. Germany Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.2.2. France Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.2.3. UK Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.2.4. Russia Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.2.5. Italy Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.2.6. Rest of Europe Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.3.      Asia-Pacific Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.3.1. China Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.3.2. Japan Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.3.3. Korea Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.3.4. India Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.3.5. Southeast Asia Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.3.6. Rest of Asia-Pacific Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.4.      South America Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.4.1. Brazil Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.4.2. Argentina Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.4.3. Columbia Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.4.4. Rest of South America Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.5.      Middle East and Africa Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.5.1. Saudi Arabia Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.5.2. United Arab Emirates Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.5.3. Egypt Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.5.4. Nigeria Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.5.5. South Africa Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.5.6. Turkey Anti-Suicide Drugs Market Forecast (2018-2025)

10.2.5.7. Rest of Middle East and Africa Anti-Suicide Drugs Market Forecast (2018-2025)

10.3. Anti-Suicide Drugs Market Forecast by Drug Class (2018-2025)

10.3.1.      Anti-Suicide Drugs Forecast by Drug Class (2018-2025)

10.3.2.      Anti-Suicide Drugs Market Share Forecast by Drug Class (2018-2025)

10.4. Anti-Suicide Drugs Market Forecast by End User (2018-2025)

10.4.1.      Anti-Suicide Drugs Forecast by End User (2018-2025)

10.4.2.      Anti-Suicide Drugs Market Share Forecast by End User (2018-2025)

 


List of Tables

List of Tables and Figures:

Figure United States Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa Anti-Suicide Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Anti-Suicide Drugs Revenue and Revenue Share by Drug Class (2014-2018)
Figure Global Anti-anxiety drugs Revenue and Growth Rate (2014-2018)
Figure Global NMDA Antagonists Revenue and Growth Rate (2014-2018)
Figure Global Anti-depressants Revenue and Growth Rate (2014-2018)
Figure Global Anti-psychotic drugs Revenue and Growth Rate (2014-2018)
Figure Global Antibiotic analogues Revenue and Growth Rate (2014-2018)
Table Global Anti-Suicide Drugs Revenue and Revenue Share by End User (2014-2018)
Figure Global Clinics Revenue and Growth Rate (2014-2018)
Figure Global Retail pharmacies Revenue and Growth Rate (2014-2018)
Figure Global Hospitals Revenue and Growth Rate (2014-2018)
Figure Global Online pharmacies Revenue and Growth Rate (2014-2018)
Table Global Anti-Suicide Drugs Revenue by Regions (2014-2018)
Figure North America Anti-Suicide Drugs Growth Rate (2014-2018)
Figure North America Anti-Suicide Drugs Revenue and Growth Rate (2014-2018)
Figure North America Anti-Suicide Drugs by Countries (2014-2018)
Figure North America Anti-Suicide Drugs Revenue (Million USD) by Countries (2014-2018)
Figure United States Anti-Suicide Drugs Growth Rate (2014-2018)
Figure United States Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Canada Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Mexico Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Europe Anti-Suicide Drugs Revenue and Growth Rate (2014-2018)
Figure Europe Anti-Suicide Drugs by Countries (2014-2018)
Figure Europe Anti-Suicide Drugs Revenue (Million USD) by Countries (2014-2018)
Figure Germany Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Germany Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France Anti-Suicide Drugs Growth Rate (2014-2018)
Figure France Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK Anti-Suicide Drugs Growth Rate (2014-2018)
Figure UK Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Russia Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Italy Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Rest of Europe Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Asia-Pacific Anti-Suicide Drugs Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific Anti-Suicide Drugs by Countries (2014-2018)
Figure Asia-Pacific Anti-Suicide Drugs Revenue (Million USD) by Countries (2014-2018)
Figure China Anti-Suicide Drugs Growth Rate (2014-2018)
Figure China Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Japan Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Korea Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India Anti-Suicide Drugs Growth Rate (2014-2018)
Figure India Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Southeast Asia Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America Anti-Suicide Drugs Growth Rate (2014-2018)
Figure South America Anti-Suicide Drugs Revenue and Growth Rate (2014-2018)
Figure South America Anti-Suicide Drugs by Countries (2014-2018)
Figure South America Anti-Suicide Drugs Revenue (Million USD) by Countries (2014-2018)
Figure Brazil Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Brazil Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Argentina Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Columbia Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Rest of South America Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Middle East and Africa Anti-Suicide Drugs Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa Anti-Suicide Drugs by Countries (2014-2018)
Figure Middle East and Africa Anti-Suicide Drugs Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Saudi Arabia Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates Anti-Suicide Drugs Growth Rate (2014-2018)
Figure United Arab Emirates Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Egypt Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Nigeria Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa Anti-Suicide Drugs Growth Rate (2014-2018)
Figure South Africa Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Turkey Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Anti-Suicide Drugs Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2014-2018)
Table Allergan plc Anti-Suicide Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table H. Lundbeck Anti-Suicide Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Anti-Suicide Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer, Inc. Anti-Suicide Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca plc Anti-Suicide Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly and Company Anti-Suicide Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline plc Anti-Suicide Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co., Inc Anti-Suicide Drugs Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Anti-Suicide Drugs Market Share by Manufacturer
Figure Global Anti-Suicide Drugs Revenue and Market Share by Manufacturer
Table Global Anti-Suicide Drugs Price by Region (2016-2017)
Figure Top 5 Anti-Suicide Drugs Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Anti-Suicide Drugs Revenue (Millions USD) and Growth Rate (2018-2025)
Table Anti-Suicide Drugs Market Forecast by Regions (2018-2025)
Figure North America Anti-Suicide Drugs Market Forecast (2018-2025)
Figure United States Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Canada Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Mexico Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Europe Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Germany Anti-Suicide Drugs Market Forecast (2018-2025)
Figure France Anti-Suicide Drugs Market Forecast (2018-2025)
Figure UK Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Russia Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Italy Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Rest of Europe Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Asia-Pacific Anti-Suicide Drugs Market Forecast (2018-2025)
Figure China Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Japan Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Korea Anti-Suicide Drugs Market Forecast (2018-2025)
Figure India Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Southeast Asia Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Anti-Suicide Drugs Market Forecast (2018-2025)
Figure South America Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Brazil Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Argentina Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Columbia Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Rest of South America Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Middle East and Africa Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Saudi Arabia Anti-Suicide Drugs Market Forecast (2018-2025)
Figure United Arab Emirates Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Egypt Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Nigeria Anti-Suicide Drugs Market Forecast (2018-2025)
Figure South Africa Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Turkey Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Anti-Suicide Drugs Market Forecast (2018-2025)
Figure Global Anti-Suicide Drugs Forecast by Drug Class (2018-2025)
Figure Global Anti-Suicide Drugs Market Share Forecast by Drug Class (2018-2025)
Figure Global Anti-Suicide Drugs Forecast by Drug Class (2018-2025)
Figure Global Anti-Suicide Drugs Forecast by End User (2018-2025)
Figure Global Anti-Suicide Drugs Market Share Forecast by End User (2018-2025)
Figure Global Anti-Suicide Drugs Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*